An Update: Predicting Individual Outcomes for Rapid Intervention (PRIORI)
Drs. Sarah Sperry and Emily Mower Provost provide an update on the PRIORI technology
Drs. Sarah Sperry and Emily Mower Provost provide an update on the PRIORI technology
In case you missed the 16th Annual Prechter Lecture: watch the video today!
The awards for the Best of T-AFFC will be presented at the hybrid 10th International Conference on Affective Computing & Intelligent Interaction that will be held online and in Nara, Japan.
Download this year's Prechter Program Newsletter and Impact Report
Dr. McInnis discusses exposure to SARS-CoV-2, acute kidney injury, and lithium toxicity from his recent publication.
Prechter Program Researchers win third place at the Eisenberg Family Depression Center Psych Tank event.
Prechter Program Director, Dr. Melvin McInnis, to moderate the Ann Arbor Jewish Book Festival with key speaker Andy Dunn, author of Burn Rate: Launching a Startup and Losing My Mind
You Are Not Alone: the NAMI Guide to Navigating Mental Health explores mental health journeys.
Prechter Program trainees win travel awards for best poster at the Society for Research in Psychopathology Conference.
Global Platform Launches to Transform Bipolar Disorder Research and Care
Prechter Program researcher, Dr. Sarah Sperry, was awarded a significant research award.
Dr. Melvin Mcinnis, Prechter Program Director, will be a key speaker at the International Society for Affective Disorder conference this September.
Prechter Program Director and Research Program Manager found instances of lithium toxicity among individuals with bipolar disorder who were diagnosed with COVID-19.
Dr. Santa J. Ono, a researcher, mental health advocate, and person living with bipolar disorder will be joining the University of Michigan as the new President.
Many Prechter Program researchers are a part of the Global Bipolar Cohort (GBC) and were involved in the studies mentioned in this article. The GBC held its inaugural meeting in Ann Arbor in 2019, organized by Dr. McInnis, Director of the Prechter Program.
People with bipolar I disorder (BD) and schizophrenia show similar difficulty with response inhibition according to a study published in Journal of Affective Disorders
The Right Support for Medication Management
Rachel has joined the Prechter Program as the Marketing and Communications Specialist
Targeting the microbiome to improve clinical outcomes in bipolar disorder